Brief: Krystal Biotech Announces FDA’s 3-Month Extension Of BLA PDUFA Date, Regulatory Update For B-VEC

Krystal Biotech

09/01/2023 13:10

Jan 9 (Reuters) - Krystal Biotech Inc  KRYS.O :
    * KRYSTAL BIOTECH ANNOUNCES FDA’S 3-MONTH EXTENSION OF BLA
PDUFA
DATE AND REGULATORY UPDATE FOR B-VEC TO TREAT PATIENTS WITH
DYSTROPHIC EPIDERMOLYSIS BULLOSA
    * KRYSTAL BIOTECH INC - PDUFA DATE HAS BEEN REVISED TO MAY
19,
2023, AND PROPOSED LABELING DISCUSSIONS TO NO LATER THAN APRIL
20, 2023

Source text for Eikon:  ID:nGNX1cqCHZ 
Further company coverage:  KRYS.O 
 ((Reuters.Briefs@thomsonreuters.com;))